NatureWise Biotech & Medicals Corporation (4732.TWO)
TWD 20.05
(0.25%)
TWD 20.05
(0.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -101.87 Million TWD | -8.39% |
| 2022 | -93.98 Million TWD | 34.28% |
| 2021 | -143 Million TWD | 9.92% |
| 2020 | -158.74 Million TWD | 34.49% |
| 2019 | -242.31 Million TWD | -779.7% |
| 2018 | -27.54 Million TWD | 28.37% |
| 2017 | -38.45 Million TWD | -49.78% |
| 2016 | -25.67 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -117.74 Million TWD | 4.37% |
| 2024 Q1 | -126.17 Million TWD | -23.86% |
| 2023 FY | -101.87 Million TWD | -8.39% |
| 2023 Q3 | -112.55 Million TWD | -24.35% |
| 2023 Q4 | -101.87 Million TWD | 9.49% |
| 2023 Q2 | -90.51 Million TWD | 5.34% |
| 2023 Q1 | -95.62 Million TWD | -1.74% |
| 2022 FY | -93.98 Million TWD | 34.28% |
| 2022 Q4 | -93.98 Million TWD | 0.0% |
| 2022 Q2 | -116.15 Million TWD | 0.0% |
| 2021 Q2 | -152.81 Million TWD | 0.0% |
| 2021 FY | -143 Million TWD | 9.92% |
| 2021 Q4 | -143 Million TWD | 0.0% |
| 2020 Q4 | -158.74 Million TWD | 0.0% |
| 2020 FY | -158.74 Million TWD | 34.49% |
| 2020 Q2 | -136.04 Million TWD | 0.0% |
| 2019 Q4 | -242.31 Million TWD | 0.0% |
| 2019 FY | -242.31 Million TWD | -779.7% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 61.438% |
| Level Biotechnology Inc. | -453.9 Million TWD | 77.557% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 120.38% |
| GlycoNex Incorporation | -148.56 Million TWD | 31.432% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 352.993% |
| OBI Pharma, Inc. | -398.22 Million TWD | 74.419% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 173.822% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 433.148% |
| Visgeneer Inc. | 31.28 Million TWD | 425.63% |
| Neith Corporation | -150.31 Million TWD | 32.227% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 75.313% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 116.39% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -76.68% |
| Enimmune corporation | -314.15 Million TWD | 67.574% |
| TaiRx, Inc. | -147.86 Million TWD | 31.108% |
| CHO Pharma, Inc. | -203.79 Million TWD | 50.013% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -20.182% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 184.28% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 69.181% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -414.157% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 300.709% |
| RBC Bioscience Corporation | 422.18 Million TWD | 124.129% |
| NaviFUS Corp. | -123.12 Million TWD | 17.266% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 89.213% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -0.378% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 38.326% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 15.51% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 420.255% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -58.378% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 67.907% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 24.12% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 57.886% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 96.835% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -32.223% |
| AP Biosciences Inc | -196.52 Million TWD | 48.165% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 85.032% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 132.353% |
| EirGenix Inc. | -4.58 Billion TWD | 97.78% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 87.722% |
| Mycenax Biotech Inc. | 207 Million TWD | 149.21% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 61.204% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 51.337% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 48.131% |
| VBI | -25.31 Million TWD | -302.394% |
| BiOptic Inc. | 12.59 Million TWD | 909.006% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 237.567% |
| Sinew Pharma Inc. | -160.34 Million TWD | 36.468% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 69.805% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 114.791% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -790.706% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 107.505% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 75.446% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 29.19% |
| TCI GENE Inc. | -689.25 Million TWD | 85.22% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 14.35% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 92.219% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 597.339% |
| PharmaEngine, Inc. | -860.8 Million TWD | 88.166% |
| Savior Lifetec Corporation | -812.54 Million TWD | 87.463% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 66.04% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 72.122% |
| Acepodia, Inc. | -6.02 Billion TWD | 98.308% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 97.005% |